Glaxo's HIV Drug May Be Linked To Heart Attack Risk - Study
GlaxoSmithKline's Ziagen, which has as its active ingredient abacavir, may be linked to increased risk of heart attack, according to an article published Wednesday online at The Lancet. Researchers studying six HIV medicines found Ziagen linked to a twofold increase in the risk of heart attack. Abacavir is also found in the combination drugs Trizivir and Epzicom. Another drug,
Videx, produced by Bristol-Myers Squibb, was linked to a 50% increased risk of heart attack.
No comments:
Post a Comment